...
机译:Celastrol衍生物作为抗卵巢癌干细胞剂的合成与生物学评价
Liaocheng Univ Sch Pharm Liaocheng 252000 Shandong Peoples R China;
Liaocheng Peoples Hosp Cent Lab Liaocheng 252000 Shandong Peoples R China;
Liaocheng Univ Sch Pharm Liaocheng 252000 Shandong Peoples R China;
Liaocheng Univ Sch Pharm Liaocheng 252000 Shandong Peoples R China;
Liaocheng Univ Sch Pharm Liaocheng 252000 Shandong Peoples R China;
Liaocheng Univ Sch Pharm Liaocheng 252000 Shandong Peoples R China;
Liaocheng Univ Sch Pharm Liaocheng 252000 Shandong Peoples R China;
Liaocheng Univ Sch Pharm Liaocheng 252000 Shandong Peoples R China;
Liaocheng Univ Sch Pharm Liaocheng 252000 Shandong Peoples R China;
Liaocheng Peoples Hosp Cent Lab Liaocheng 252000 Shandong Peoples R China;
Celastrol derivatives; Antiproliferative; Cancer stem cell; Ovarian cancer;
机译:Celastrol衍生物作为抗卵巢癌干细胞剂的合成与生物学评价
机译:C(6) - 吲哚Celastrol衍生物作为潜在抗肿瘤剂的设计,合成和生物学评价
机译:C(6)修饰的Celastrol衍生物作为潜在抗肿瘤药物的设计,合成和生物学评估
机译:3-苯基异恶唑的设计,合成和生物学评价5,4-D嘧啶衍生物作为抗癌剂
机译:新型白藜芦醇和Combretastatin A4衍生物作为强效抗癌药的合成及生物学评价。
机译:C(6)修饰的Celastrol衍生物作为潜在抗肿瘤药物的设计合成和生物学评估
机译:C(6) - 改性Celastrol衍生物作为潜在抗肿瘤药物的设计,合成及生物学评价